Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Leading Health & Wellness Doctor, Jeff Toll, to Medical Advisory Board

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed noted expert in internal medicine, Dr. Jeff...
June 09, 2020 08:02 ET | Source: Conversion Labs, Inc.

Conversion Labs Reports May 2020 Net Revenues up 274% to Record $3.2 Million, on Track to Exceed 3x Growth in 2020

NEW YORK, June 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record net revenues of $3.2 million for the month...
May 19, 2020 15:00 ET | Source: Conversion Labs, Inc.

Conversion Labs Reports Revenue up 59% to Record $4.3 Million in Q1 2020; Raises 2020 Revenue Outlook to Exceed $36 Million

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the first quarter ended March 31, 2020. ...
May 11, 2020 09:00 ET | Source: Conversion Labs, Inc.

Conversion Labs Expands Capabilities of Telemedicine Platform as Sales in April More Than Double

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has begun the roll out of a new cloud-based, end-to-end...
April 21, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Reports Preliminary First Quarter 2020 Revenue Up 60% to Record $4.3 Million

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited revenue of approximately $4.3...
April 14, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Award-Winning Physician, Dr. Jeremy Fine, to Advisory Board to Advance Telemedicine Brand Portfolio

NEW YORK, April 14, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed Dr. Jeremy Fine, a noted expert in internal...
March 31, 2020 09:29 ET | Source: Conversion Labs, Inc.

Conversion Labs Reports Revenue up 81% to Record $3.9 Million in Q4 2019, up 50% to Record $12.5 Million for Full Year

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the fourth quarter and full year ended...
March 26, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Receives FDA Clearance for Shapiro MD Laser Hair Restoration Device

NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received FDA 510(k) clearance for its new hair regrowth...
March 23, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Donates 10,000 Bottles of Beta Glucan Immune Support Supplement to Healthcare Workers, First Line Responders, and COVID-19 Patients

NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, is demonstrating its support for those leading the fight...
March 19, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Launches SOSRx Disaster Pack: Essential Prescription Medications for Disaster Scenarios Delivered via Telehealth

NEW YORK, March 19, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its long-awaited new telemedicine...